Velvette International Pharma Products Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 04-12-2024
- Paid Up Capital ₹ 4.93 Cr
as on 04-12-2024
- Company Age 39 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.22 Cr
as on 04-12-2024
- Satisfied Charges ₹ 2.00 Cr
as on 04-12-2024
- Revenue %
(FY 2022)
- Profit 2.30%
(FY 2022)
- Ebitda -51.99%
(FY 2022)
- Net Worth -1.40%
(FY 2022)
- Total Assets -7.76%
(FY 2022)
About Velvette International Pharma Products
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 4.93 Cr.
The company currently has active open charges totaling ₹6.22 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sujatha Rajkumar, Vimalkumar Damodharam, Senthurvasan Narayanaswamy, and One other member serve as directors at the Company.
- CIN/LLPIN
L24231TN1985PLC011479
- Company No.
011479
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jan 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Velvette International Pharma Products?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthurvasan Narayanaswamy  | Director | 02-Aug-2004 | Current |
| Sujatha Rajkumar | Whole-Time Director | 02-Jan-1998 | Current |
| Vimalkumar Damodharam | Director | 21-Sep-2005 | Current |
| Ramamoorthy Vasudevan | Director | 18-Oct-2021 | Current |
Financial Performance of Velvette International Pharma Products.
Velvette International Pharma Products Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.3% increase in profit. The company's net worth dipped by a decrease of 1.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Velvette International Pharma Products?
In 2022, Velvette International Pharma Products had a promoter holding of 31.22% and a public holding of 68.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bobvithan Tube & Machineries Private LimitedActive 49 years 10 monthsSujatha Rajkumar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Madura Limited Creation Date: 14 Jan 1995 | ₹1.90 M | Open |
Bank Of Rajasthan Creation Date: 22 Dec 1994 | ₹3.50 Cr | Open |
Bank Of Baroda Creation Date: 15 Mar 1994 | ₹1.95 Cr | Open |
How Many Employees Work at Velvette International Pharma Products?
Velvette International Pharma Products has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Velvette International Pharma Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Velvette International Pharma Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
